Literature DB >> 2435886

Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterization of muscarinic receptors.

G M Rubanyi, M McKinney, P M Vanhoutte.   

Abstract

Experiments were designed to compare the release of endothelium-derived relaxing factor(s) in response to various muscarinic receptor agonists from canine femoral arteries mounted in organ chambers or perfused in a bioassay system. In rings of femoral arteries, suspended for isometric tension recording in organ chambers, acetylcholine induced endothelium-dependent relaxations during contractions evoked by prostaglandin F2 alpha. Atropine and pirenzepine antagonized these relaxations in a competitive manner, atropine with a higher affinity (KB = 1.9 X 10(-9) M) than pirenzepine (KB = 5.4 X 10(-7) M). Carbachol and McN-A-343 also evoked endothelium-dependent relaxations, and pirenzepine inhibited these responses with a similar low potency. The order of relative potency of the agonists in organ chamber studies was acetylcholine = carbachol much greater than McN-A-343. Isolated segments of femoral arteries with endothelium were perfused (2 ml/min) with modified Krebs-Ringer-bicarbonate solution containing indomethacin; the perfusate was bioassayed for endothelium-derived relaxing factor(s) by means of a ring of coronary artery without endothelium. When infused above but not below the femoral artery, low concentrations (10(-8)-10(-7) M) of acetylcholine caused transient relaxations of the bioassay ring contracted with prostaglandin F2 alpha; higher concentrations of acetylcholine caused sustained decreases in tension. Atropine inhibited the two phases of the concentration-relaxation curve with similar potencies. Pirenzepine inhibited both phases in a competitive manner but exhibited significantly higher potency against the first- (ED50, 1.9 X 10(-9) M) than against the second-phase responses (ED50, 2.1 X 10(-7) M). Compound McN-A-343 induced only transient decreases in tension, whereas carbachol caused sustained relaxations.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435886

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  M1 and M3 muscarinic receptors in human pulmonary arteries.

Authors:  X Norel; L Walch; M Costantino; C Labat; I Gorenne; E Dulmet; F Rossi; C Brink
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

2.  Evidence for a M(1) muscarinic receptor on the endothelium of human pulmonary veins.

Authors:  L Walch; J P Gascard; E Dulmet; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Endothelium modulation of the effects of nitroglycerin on blood vessels from dogs with pacing-induced heart failure.

Authors:  C Forster; J S Main; P W Armstrong
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

4.  A relaxing factor released by phospholipase A2 in the absence of endothelium.

Authors:  R J Bing; M Saeed
Journal:  Mol Cell Biochem       Date:  1987-11       Impact factor: 3.396

5.  The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptors in vitro.

Authors:  R M Eglen; W W Montgomery; I A Dainty; L K Dubuque; R L Whiting
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

6.  Mediation by M3-muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of the spontaneously hypertensive rat.

Authors:  C M Boulanger; K J Morrison; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

7.  Differential inhibition by NG-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature.

Authors:  P J Chowienczyk; J R Cockcroft; J M Ritter
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.